{{Rsnum
|rsid=2722425
|Gene=ZMAT4
|Chromosome=8
|position=40626720
|Orientation=minus
|GMAF=0.2466
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ZMAT4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 18.6 | 81.4
| HCB | 13.1 | 37.2 | 49.6
| JPT | 8.8 | 34.5 | 56.6
| YRI | 19.9 | 49.3 | 30.8
| ASW | 12.3 | 54.4 | 33.3
| CHB | 13.1 | 37.2 | 49.6
| CHD | 5.5 | 45.9 | 48.6
| GIH | 5.9 | 33.7 | 60.4
| LWK | 14.5 | 45.5 | 40.0
| MEX | 8.6 | 50.0 | 41.4
| MKK | 15.4 | 44.9 | 39.7
| TSI | 2.0 | 16.7 | 81.4
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs2722425
|PubMedID=17903298
|Condition=Fasting plasma glucose
|Gene=ZMAT4
|Risk Allele=
|pValue=2.00E-008
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2722425
|Name_s=
|Gene_s=ZMAT4
|Feature=
|Evidence=PubMed ID:17903298; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association with diabetes-related traits in the Framingham Heart Study (Initial Sample Size: 1,087 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Fasting plasma glucose.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356530
}}

{{PMID|17903291|OA=1
}} The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2722425
|overall_frequency_n=97
|overall_frequency_d=128
|overall_frequency=0.757812
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=84
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}